Bibliography
- Bonuccelli U, Meco G, Fabbrini G, A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease. Expert Opin Pharmacother 2012;13:2269-80
- Lieberman A. Depression in Parkinson's disease–a review. Acta Neurol Scand 2006;113:1-8
- Aarsland D, Pahlhagen S, Ballard CG, Depression in Parkinson disease–epidemiology, mechanisms and management. Nature reviews. Neurology 2012;8:35-47
- Gallagher DA, Schrag A. Psychosis, apathy, depression and anxiety in Parkinson's disease. Neurobiol Dis 2012;46:581-9
- Politis M, Wu K, Loane C, Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010;75:1920-7
- Black KJ, Hershey T, Koller JM, A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci USA 2002;99:17113-18
- Corrigan MH, Denahan AQ, Wright CE, Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 2000;11:58-65
- Frisina PG, Tenenbaum HR, Borod JC, The effects of antidepressants in Parkinson's disease: a meta-analysis. Int J Neurosci 2008;118:667-82
- Dobkin RD, Menza M, Bienfait KL, Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. Am J Geriatr Psychiatry 2011;19:222-9
- Fernandez HH. Updates in the medical management of Parkinson disease. Cleve Clin J Med 2012;79:28-35
- Latoo J, Mistry M, Dunne FJ. Depression in Parkinson's disease: diagnosis and management. Br J Hosp Med (Lond) 2012;73:331-4
- Cipriani A, Furukawa TA, Salanti G, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373:746-58
- Cipriani A, Koesters M, Furukawa TA, Duloxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev 2012;10:CD006533
- Gony M, Lapeyre-Mestre M, Montastruc JL. Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs. Clin Neuropharmacol 2003;26:142-5
- Madhusoodanan S, Alexeenko L, Sanders R, Extrapyramidal symptoms associated with antidepressants–a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010;22:148-56
- Richard IH, McDermott MP, Kurlan R, A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012;78:1229-36